Loading clinical trials...
Loading clinical trials...
Evaluation of the Capacity of a Weekly Strategy of 4 Consecutive Days on Treatment Followed by 3 Days Off Treatment, in HIV-1 Infected Patients With Undetectable Viral Load for at Least 12 Months, to Maintain a Virological Success With This Intermittent Maintenance Therapy After a Successful Continuous Induction Therapy.
Conditions
Interventions
Four consecutive days on treatment and 3 days off
Locations
17
France
Hôpital Meynard
Fort-de-france, Martinique, France
Hôpital Avicenne
Bobigny, France
CHU Côte de Nacre
Caen, France
Centre Hospitalier Sud Francilien
Corbeil-Essonnes, France
Hôpital Le Bocage
Dijon, France
Hôpital Raymond Poincaré
Garches, France
Start Date
July 1, 2014
Primary Completion Date
January 1, 2016
Completion Date
January 1, 2016
Last Updated
January 27, 2016
NCT06602622
NCT06185452
NCT06902038
NCT03835546
NCT03212989
NCT04620304
Lead Sponsor
ANRS, Emerging Infectious Diseases
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions